Opinion|Videos|October 4, 2024
Fast-Tracking Care: Streamlining Referrals for Quicker Treatment in Multiple Myeloma
Panelists discuss how streamlining the referral process for multiple myeloma patients can significantly reduce treatment initiation.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can we streamline the referral process to reduce delays between initial patient identification and treatment initiation?
- What additional resources or support would be most helpful in optimizing the referral process for these therapies?
Advertisement
Related to this article
In a phase 2 trial, CD38-targeted immune-PET detected active multiple myeloma in some patients with no signs of disease on standard fluorodeoxyglucose PET/CT.
“If it is successful, you should be able to access this combination wherever you are,” said Natalie S. Callander, MD, of the UW Carbone Cancer Center.
Advertisement
Advertisement
Trending on CancerNetwork
1
Azacitidine Plus Ruxolitinib Shows Durable Responses in Myelofibrosis
2
Defining the Optimal Window for Cytoreductive SABR in Metastatic Kidney Cancer
3
Building Systems to Catch Liver and Other Cancers in Patients With MASLD
4
Rusfertide Improves Hematocrit Control vs Placebo in Polycythemia Vera
5